Peer Review reports
From: AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
Original Submission | ||
---|---|---|
6 Mar 2015 | Submitted | Original manuscript |
Author responded | Author comments | |
Reviewed | Reviewer Report | |
Reviewed | Reviewer Report | |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Author responded | Author comments | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
Author responded | Author comments | |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Author responded | Author comments | |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
Publishing | ||
6 Nov 2015 | Editorially accepted | |
14 Nov 2015 | Article published | 10.1186/s12885-015-1916-3 |
You can find further information about peer review here.